Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Ginkgo Bioworks to Host 5th Annual Ferment Conference


BOSTON, April 4, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference, Ferment, on Thursday, April 11, 2024 in Boston, MA. The conference brings together stakeholders from across the synthetic biology ecosystem and the Ginkgo community, from shareholders and customers to suppliers, academics, and many more.

Because we have reached in-person capacity, a video livestream of the event will be made available to the public, including on Ginkgo's YouTube channel and on the company's investor relations website at https://investors.ginkgobioworks.com/events.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

GINKGO BIOWORKS INVESTOR CONTACT:
[email protected]

GINKGO BIOWORKS MEDIA CONTACT:
[email protected]

SOURCE Ginkgo Bioworks


These press releases may also interest you

at 20:15
Copart, Inc. announced today that it will release earnings for the third quarter of fiscal 2024 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, May 16, 2024. On Thursday, May 16, 2024, at 5:30 p.m. Eastern Time (4:30 p.m. Central),...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 20:00
SK hynix Inc. (or "the company", www.skhynix.com) announced today that it has developed the Zoned UFS, or ZUFS* 4.0, a mobile NAND solution product for on-device** AI...

at 19:31
In an innovative collaboration, Cervo Media Group Inc and Red Tusk Records are set to unveil "Pandora's Box," a musical experience that promises to redefine the very essence of contemporary classical music. Not just a composition, Pandora's Box is a...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...

at 19:15
Silvaco Group, Inc. ("Silvaco"), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and AI through software and innovation, today announced the pricing of its initial public offering of 6,000,000 shares of its common...



News published on and distributed by: